Exscientia plc (EXAI) Q3 2022 Earnings Call Transcript

Nov. 15, 2022 1:09 PM ETExscientia plc (EXAI)
SA Transcripts profile picture
SA Transcripts

Exscientia plc (NASDAQ:EXAI) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET

Company Participants

Sara Sherman - Vice President-Investor Relations

Andrew Hopkins - Chief Executive Officer & Executive Director

Ben Taylor - Chief Financial Officer & Chief Strategy Officer

Dave Hallett - Chief Operating Officer

Mike Krams - Chief Quantitative Medicine Officer

Garry Pairaudeau - Chief Technology Officer

Conference Call Participants

Michael Ryskin - Bank of America


Hello, everyone. My name is Brent and I will be your conference operator today. At this time, I would like to welcome everyone to Exscientia's Business Update Call for the Third Quarter of 2022. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Thank you.

At this time, I'd like to introduce Sara Sherman, Vice President of Investor Relations. Sara, you may begin.

Sara Sherman

Thank you, operator. A press release and 6-K were issued this morning with our third quarter 2022 financial results and business updates. These documents can be found on our website at www.investors.exscientia.ai along with the presentation for today's webcast.

Before we begin, I'd like to remind you that we may make forward-looking statements on our call. These may include statements about our projected growth, revenue, business models, preclinical and clinical results, and business performance. Actual results may differ materially from those indicated by these statements. Unless required by law Exscientia does not undertake any obligation to update these statements regarding the future or to confirm these statements in relation to actual results.

On today's call, I'm joined by Andrew Hopkins Chief Executive Officer; and Ben Taylor, CFO and Chief Strategy Officer. Dave Hallett, Chief Operating Officer; Mike Krams, Chief Quantitative Medicine Officer; and Gary Pairaudeau, Chief Technology Officer will also be available for the Q&A session.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.